U.S. Supreme Court unanimously strikes down legal challenge to abortion pill mifepristone

The ruling preserves access to the mail-order medication nationwide.

By Devin Dwyer
June 13, 2024

The U.S. Supreme Court on Thursday ruled a group of doctors lacked legal standing to challenge the Food and Drug Administration's regulation of the abortion pill mifepristone, preserving access to the medication nationwide.

The unanimous opinion was authored by Justice Brett Kavanaugh.

The case put abortion access back in the spotlight for the court for the first time since its conservative majority voted to overrule Roe v. Wade in 2022.

Continued: https://abcnews.go.com/Politics/supreme-court-unanimously-strikes-legal-challenge-abortion-pill/story?id=110439079

An 1873 law banned the mailing of boxing photos. Could it block abortion pills, too?

APRIL 5, 2024 

WASHINGTON — An anti-obscenity law enacted in 1873 that hasn’t been enforced in decades shot to the forefront of the nation’s abortion debate in the past week thanks to two U.S. Supreme Court justices, amid expectations a future Republican president would use the law to order a nationwide ban on medication abortion.

The Comstock Act, which prohibited the mailing of anatomy textbooks and boxing photographs as well as contraceptives, drew fresh attention after Justices Samuel Alito and Clarence Thomas during March 26 oral arguments seemed to suggest the law would block the mailing of mifepristone.

Continued: https://missouriindependent.com/2024/04/05/an-1873-law-banned-the-mailing-of-boxing-photos-could-it-block-abortion-pills-too/

USA – The Anti-Abortion Movement’s Biggest Fear

MARCH 25, 2024

On Tuesday, the Supreme Court is scheduled to hear oral arguments in FDA v. Alliance for Hippocratic Medicine, a case that could determine national access to mifepristone, one of two pills used as part of medication abortion. In this week’s episode of Amicus, Dahlia Lithwick spoke with Carrie N. Baker, whose book, History and Politics of Abortion Pills in the United States, is being published by Amherst College Press this year.

Lithwick and Baker discussed the anti-abortion movement’s decadeslong efforts to target the abortion pill, how those efforts hampered FDA approval of the medication in the first place, and how having easier access to reproductive care through a pill that can be sent in the mail and taken at home fundamentally threatens the strategy of those seeking to dismantle abortion rights in this country. The following transcript has been edited for length and clarity.

Continued: https://slate.com/news-and-politics/2024/03/abortion-pill-supreme-court-preview-mifepristone-history.html

Abortion pill mifepristone: An explainer and research roundup about its history, safety and future

Amid pending court cases and ballot initiatives, journalistic coverage of medication abortion has never been more crucial. This piece aims to help inform the narrative with scientific evidence.

by Naseem S. Miller
November 1, 2023

Access to mifepristone, a medication that’s used for the safe termination of early pregnancy, hangs in the balance while the U.S. Supreme Court decides whether to take up a case that could determine the legal future of the abortion medication.

In August, the 5th U.S. Circuit Court of Appeals ruled that mifepristone should not be prescribed past the seventh week of pregnancy, prescribed via telemedicine, or shipped to patients through the mail. In September, the Justice Department asked the Supreme Court to consider a challenge to that ruling.

Continued: https://journalistsresource.org/health/mifepristone-research-roundup/

USA – Many women can’t access miscarriage drug because it’s also used for abortions

OCTOBER 21, 2023

Since losing her first pregnancy four months ago, 32-year-old Lulu has struggled to return to her body’s old rhythms. Lulu, who asked to be identified by her first name to protect her privacy, bled for six full weeks after her miscarriage and hasn’t had a normal menstrual cycle since.

Such disruptions aren’t uncommon after miscarriage, which affects roughly 1 in 10 known pregnancies. But for Lulu, they’ve also served as a persistent reminder that she couldn’t access the drug mifepristone — her preferred method of care — to help her body pass the miscarriage. Instead, her doctor prescribed a drug called misoprostol, which on its own is less effective.

Continued: https://ncnewsline.com/2023/10/21/many-women-cant-access-miscarriage-drug-because-its-also-used-for-abortions/

Justice Dept and abortion pill manufacturer ask Supreme Court to hear case on mifepristone access


Danco Laboratories, the drugmaker of the abortion pill mifepristone, has asked the Supreme Court to review a lower court's decision limiting access to the pill, the company announced in a news release Friday. On Friday evening, the Justice Department also asked the Supreme Court to review the Fifth Circuit's judgment.

Danco and the Justice Department want the Supreme Court to reverse the circuit court's ruling that would prevent women from obtaining the drug by mail order and would prohibit the pill after seven weeks of pregnancy.

Continued: https://www.cbsnews.com/news/abortion-pill-mifepristone-fda-approval-justice-department-supreme-court/

Federal judges grill Biden administration on abortion pill

During a two-hour oral argument, the judges appeared sympathetic to an anti-abortion medical group seeking to revoke the FDA’s approval of mifepristone.


NEW ORLEANS — Three federal judges seemed poised to rule against the Biden administration in its efforts to preserve access to the abortion drug mifepristone.

During an occasionally combative, two-hour hearing Wednesday before a panel of the 5th Circuit Court of Appeals, the judges — all Republican appointees — grilled attorneys from the Justice Departments and Danco Laboratories, the pill’s manufacturer, who are battling to keep the drug available in the U.S.

Continued: https://www.politico.com/news/2023/05/17/federal-judges-appear-skeptical-of-biden-administration-in-abortion-pills-case-00097477

USA – Abortion pill legal challenge threatens miscarriage care

One of the most widely used treatments for miscarriage is in jeopardy

By LAURA UNGAR AP Science Writer
May 6, 2023

Less than a year after losing her daughter Emilia at five days old, Jillian Phillips suffered a miscarriage. It was Halloween weekend in 2016, and her doctor said she could wait for it to end naturally, have a surgical procedure or take medication.

She chose the medicine, passed the remains of her nine-week pregnancy at home and buried them in a memorial garden, near some of Emilia’s ashes.

Continued: https://abcnews.go.com/Health/wireStory/abortion-pill-legal-challenge-threatens-miscarriage-care-99136739

Abortion pill mifepristone remains legal for now. What happens next?

UT law professor Stephen Vladeck discusses what’s to come in the ongoing legal challenges to abortion after the Supreme Court voted to preserve access to the abortion pill.

By Glorie Martinez and Laura Rice
April 24, 2023

Last Friday, the U.S. awaited action from the Supreme Court in the biggest case involving abortion since Roe v. Wade was overturned. That case traces back to a recent ruling by federal judge Matthew Kacsmaryk in Amarillo, who revoked FDA approval for the abortion pill mifepristone which has been widely available since the early 2000s.

Within minutes of the Amarillo ruling, another federal judge in Washington State issued an order for the FDA to keep mifepristone available – a direct challenge to competing court orders. To prevent regulatory chaos, the Biden administration asked the Supreme Court to intervene.

Continued: https://www.texasstandard.org/stories/abortion-pill-mifepristone-remains-legal-for-now-what-happens-next/

US supreme court blocks ruling limiting access to abortion pill

Federal judge in Texas ruled in early April to suspend FDA-approved mifepristone used in more than half of abortions in US

Poppy Noor and agencies
Sat 22 Apr 2023

The supreme court decided on Friday to temporarily block a lower court ruling that had placed significant restrictions on the abortion drug mifepristone.

The justices granted emergency requests by the justice department and the pill’s manufacturer, Danco Laboratories, to halt a preliminary injunction issued by a federal judge in Texas. The judge’s order would significantly limit the availability of the medication as litigation proceeds in a challenge by anti-abortion groups.

Continued: https://www.theguardian.com/world/2023/apr/21/abortion-pill-ruling-latest-news-supreme-court-decision